SCHEMBL221385

SCHEMBL221385

O=C(O)/C=C(\OO)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.35
KDM4E B2RXH2 1/20 0.35
TP53 P04637 1/20 0.30
EGLN1 Q9GZT9 1/20 0.30
EGLN3 Q9H6Z9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL221900 1.00 TSHR (0.35) TSHRKDM4ETP53EGLN1EGLN3
SCHEMBL5498850 1.00 TSHR (0.35) TSHRKDM4ETP53EGLN1EGLN3
SCHEMBL542267 0.74 HCAR2 (0.40) TSHRKDM4E
SCHEMBL542268 0.74 HCAR2 (0.40) TSHRKDM4E
SCHEMBL542266 0.74 HCAR2 (0.40) TSHRKDM4E
SCHEMBL21291677 0.72 LMNA (0.38) TSHRKDM4E
SCHEMBL731658 0.72 LMNA (0.38) TSHRKDM4E
SCHEMBL11129144 0.70 HCAR2 (0.32) TSHRKDM4E
SCHEMBL29022487 0.70 HCAR2 (0.32) TSHRKDM4E
SCHEMBL7745871 0.70 TSHR (0.43) TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3080610-A1 UNIVERSAL ANTIGEN RETRIEVAL COMPOUNDS AND METHODS OF USE University of Houston System (US) 2016-10-19 EP claimed
CN-106030309-A Universal antigen retrieval compounds and methods of use thereof 休斯敦大学系统 2016-10-12 CN claimed
US-20150168417-A1 Universal Antigen Retrieval Compounds and Methods of Use UNIVERSITY OF HOUSTON SYSTEM (US) 2015-06-18 US claimed
WO-2015088667-A1 UNIVERSAL ANTIGEN RETRIEVAL COMPOUNDS AND METHODS OF USE UNIVERSITY OF HOUSTON SYSTEM (US) 2015-06-18 WO claimed
US-20050090668-A1 Preparation of 5-hydroxy-6-oxo-1,6-dihydropyrimidine compounds DREHER SPENCER D (US) 2005-04-28 US claimed
US-6849705-B2 Bifunctional polyaddition compounds as crosslinkers for polyurethane powder coatings DEGUSSA AG (DE) 2005-02-01 US claimed
US-20030212239-A1 Bifunctional polyaddition compounds as crosslinkers for polyurethane powder coatings DEGUSSA AG (DE) 2003-11-13 US claimed
EP-3315968-B1 UNIVERSAL ANTIGEN RETRIEVAL COMPOUNDS AND METHODS OF USE UNIV HOUSTON SYSTEM (US) 2025-10-15 EP disclosed
WO-2024071123-A1 EASILY ADHESIVE POLYAMIDE FILM AND METHOD FOR PRODUCING SAME ユニチカ株式会社 2024-04-04 WO disclosed
CN-117777396-A Heat-sealable aqueous resin composition and laminate 荒川化学工业株式会社 2024-03-29 CN disclosed
US-20240101818-A1 AQUEOUS HEAT-SEALABLE RESIN COMPOSITION AND LAMINATE ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) 2024-03-28 US disclosed
US-20230077630-A1 WATER-BASED COMPOSITION FOR BARRIER AND LAMINATED MATERIAL ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) 2023-03-16 US disclosed
CN-115725231-A Water-based composition for barrier and laminate 荒川化学工业株式会社 2023-03-03 CN disclosed
US-6849705-B2 Bifunctional polyaddition compounds as crosslinkers for polyurethane powder coatings DEGUSSA AG (DE) 2005-02-01 US disclosed
US-20030212239-A1 Bifunctional polyaddition compounds as crosslinkers for polyurethane powder coatings DEGUSSA AG (DE) 2003-11-13 US disclosed
US-6313196-B1 FOR INK JET PRINTING; SMUDGE RESISTANCE AGFA-GEVAERT (BE) 2001-11-06 US disclosed
US-5693737-A POLYETHERURETHANES FOR PREPARING CREASE-RESISTANT TEXTILES BAYER AKTIENGESELLSCHAFT (DE) 1997-12-02 US disclosed
US-5607482-A BLOCKED POLYISOCYANATE BAYER AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed
US-5508370-A POLYETHERURETHANE COPOLYMER; TEXTILE FINISH BAYER AKTIENGESELLSCHAFT (DE) 1996-04-16 US disclosed
US-4544683-A GYPSUM-POLYURETHANE OR POLYURETHANE-POLYUREA BAYER AKTIENGESELLSCHAFT (DE) 1985-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090668-A1 Preparation of 5-hydroxy-6-oxo-1,6-dihydropyrimidine compounds DPYD, DHODH, DHPS TSHR 4498/4885KDM4E 1806/4885TP53 1209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.